PeptiSystems AB

PeptiSystems offers a new generation of flow-through instruments for solid-phase peptide and oligonucleotide therapeutics synthesis. Based on flow-through column technology, our instruments are used within the biopharmaceutical and biotech industry for process development and large-scale GMP and non-GMP manufacturing. Chemistry first - our instruments are designed from a chemistry perspective to give maximum flexibility and control without compromise

Peptide synthesis,oligonucleotide synthesis,flowthrough column technology,continuous flow,organic chemistry,and synthesis instruments

Peptisystems ab's revenue is 11m - 100m

Peptisystems ab has 11 - 50 employees.